Dr. Adam Kinnaird, MD
Claim this profileUniversity of Alberta
Studies Prostate Cancer
4 reported clinical trials
8 drugs studied
Affiliated Hospitals
Clinical Trials Adam Kinnaird, MD is currently running
ClarityDX Prostate
for Prostate Cancer
ClarityDX Prostate builds upon the utility of total and free PSA as well as simple clinical features in a decision support model to determine a patient's risk of having clinically significant prostate cancer. The highly accurate ClarityDX Prostate risk score enables clinicians and patients to collectively make more informed decisions regarding the appropriateness of subsequent imaging or biopsy procedures. The clinical pathway aligns with the Canadian Urological Association (CUA) to use adjunctive strategies to better stratify risk of clinically significant prostate cancer. ClarityDX Prostate consists of four separate models that can be used depending on the information available: 1. ClarityDX Prostate. This model incorporates the patient's total PSA and free PSA levels as well as the age of the patient and whether they have had a previous negative biopsy. 2. ClarityDX Prostate + DRE. This model incorporates ClarityDX Prostate + DRE (normal or abnormal DRE findings). 3. ClarityDX Prostate + MRI. This model incorporates ClarityDX Prostate + MRI (PI-RADS score and prostate volume as determined from an mpMRI scan). 4. ClarityDX Prostate + MRI + DRE. This model incorporates ClarityDX Prostate + MRI + DRE. PRIMARY OBJECTIVE The purpose of this study is to investigate the clinical utility of ClarityDX Prostate on in reducing further healthcare utilization for men identified to be at risk of prostate cancer. SECONDARY OBJECTIVES * Assess the effect of ClarityDX Prostate on the proportion of negative biopsies and biopsies diagnosing Gleason Grade (GG)\<2. * Measure the difference in MRI numbers between the test and control groups. * Evaluate the effect of ClarityDX Prostate on the prioritization of healthcare services to participants with high-risk of having clinically significant prostate cancer. * Infer the potential to use ClarityDX Prostate for prostate cancer screening to inform urology referral. * Perform a health economics assessment and cost-benefit analysis for the use of ClarityDX Prostate. This is a prospective, randomized, two-armed clinical utility study that will enroll participants referred to urology clinics for suspicion of prostate cancer. The arms of the study are ClarityDX Prostate and Standard of Care (SOC).
Recruiting1 award N/A3 criteria
Micro-Ultrasound Imaging
for Prostate Cancer
This study will compare the two imaging modalities (MRI and micro-ultrasound) during Active Surveillance of prostate cancer (PCa). Progression to clinically significant PCa will be assessed by first taking micro-US targeted samples (while blinded to MRI results), followed by MRI targeted samples, finishing with 12 systematic biopsy cores. The primary goal is to compare microUS to MRI for the detection of ≥GG2 PCa at confirmatory biopsy. This study will also collect blood samples from participants to be used for future biomarker studies.
Recruiting1 award N/A
More about Adam Kinnaird, MD
Clinical Trial Related3 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Adam Kinnaird, MD has experience with
- ClarityDX Prostate
- Micro-US Targeted Biopsy
- MRI Targeted Biopsy
- 18F-PSMA-1007 PET
- 99mTc-MDP Bone Scan
- CT Abdomen/Pelvis
Breakdown of trials Adam Kinnaird, MD has run
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Adam Kinnaird, MD specialize in?
Adam Kinnaird, MD focuses on Prostate Cancer and other conditions. In particular, much of their work with Prostate Cancer has involved treating patients, or patients who are undergoing treatment.
Is Adam Kinnaird, MD currently recruiting for clinical trials?
Yes, Adam Kinnaird, MD is currently recruiting for 2 clinical trials in Edmonton Alberta. If you're interested in participating, you should apply.
Are there any treatments that Adam Kinnaird, MD has studied deeply?
Yes, Adam Kinnaird, MD has studied treatments such as ClarityDX Prostate, Micro-US Targeted Biopsy, MRI Targeted Biopsy.
What is the best way to schedule an appointment with Adam Kinnaird, MD?
Apply for one of the trials that Adam Kinnaird, MD is conducting.
What is the office address of Adam Kinnaird, MD?
The office of Adam Kinnaird, MD is located at: University of Alberta, Edmonton, Alberta T6G1Z1 Canada. This is the address for their practice at the University of Alberta.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.